The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

Krakatoa Resources Ltd (ASX: KTA) has picked up an unexpected copper-gold mineralisation through early exploration at a new prospect close to the Hills End gold mine in New South Wales.

Expecting only to find lode gold, Krakatoa instead found both good grades of gold – up to 1.24 gram per tonne – but also 10.45 percent copper being lifted from reconnaissance and rock chipping work at the Jews Creek prospect.

The precious and base metals junior company was also sniffing at another project – Mount Rosette – which joins Jews Creek as one of several exploration sites with Krakatoa’s Turon project near Bathurst.

Assaying results also indicated the presence of molybdenum and tin within the new prospect, and four samples returned copper grades averaging 4.83 percent, to a maximum of 10.45 percent.

Krakatoa CEO Mark Major said the unexpected find would propel more detailed work in the future.

“Our NSW Projects continue to deliver promising results,” he said.

“Jews Creek Prospect within the Turon tenement, widely considered prospective for lode gold only, has delivered encouraging, intrusive-related Cu-Au results at a time when the demand for copper is booming and gold is threatening to break out to an all-time high.

“These are promising results, and we look forward to future investigations.”

Krakatoa is trading at 0.8c.

KTA by the numbers
More From The Market Online
Organised crime concept

Panic, paranoia, and gangland politics: HotCopper users react to Dubber’s missing $26M

HotCopper users have reacted to overnight reports Dubber has seen $26M disappear from its coffers due…
The Market Online Video

ASX Market Update: Bourse nears record approaching week’s end | November 22, 2024

The bourse is near record territory to close out the week on the back of a…
Image of four gold necklaces

Sales growth pushes Lovisa’s fortunes (and shares) upwards

Lovisa Holdings Ltd has seen its shares rise more than 2% following a sales update, and…
Image of eyes in closeup

Scientific conference spotlights PYC’s work on blindness disease treatment

PYC Therapeutics Ltd will have data from its ongoing trial into a drug candidate to treat…